BIOMAT Database Logo BIOMAT Database Logo

Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection. 2020

Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States.

The effective treatment of adenovirus (HAdV) infections in immunocompromised patients still poses great challenges. Herein, we reported our continued efforts to optimize a series of salicylamide derivatives as potent inhibitors of HAdV infection. Of these, nine compounds (11, 13, 14, 17, 20, 58, 60, 62, and 70) showed significantly improved anti-HAdV activities with nanomolar to submicromolar IC50 values and high selectivity indexes (SI > 100), indicating better safety windows, compared to those of the lead compound niclosamide. Our mechanistic assays suggest that compounds 13, 62, and 70 exert their activities in the HAdV entry pathway, while compounds 14 and 60 likely target the HAdV DNA replication, and 11, 17, 20, and 58 inhibit later steps after DNA replication. Given the broad anti-viral activity profile of niclosamide, these derivatives may also offer therapeutic potential for other viral infections.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D000260 Adenoviruses, Human Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G. APC Viruses,APC Virus,Adenovirus, Human,Human Adenovirus,Human Adenoviruses
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012457 Salicylamides Amides of salicylic acid.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents.
April 2022, European journal of medicinal chemistry,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
March 2005, Bioorganic & medicinal chemistry letters,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Synthesis and Structure-Activity Relationship of Salvinal Derivatives as Potent Microtubule Inhibitors.
March 2023, International journal of molecular sciences,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
August 2019, Biomolecules,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Synthesis and structure-activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease.
August 2014, Bioorganic & medicinal chemistry,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Structure-ATPase Activity Relationship of Rhodamine Derivatives as Potent Inhibitors of P-Glycoprotein CmABCB1.
February 2024, ACS medicinal chemistry letters,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
February 2022, Bioorganic chemistry,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
October 2004, The Journal of pharmacy and pharmacology,
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Structure-Activity Relationship Studies Based on Quinazoline Derivatives as EGFR Kinase Inhibitors (2017-Present).
April 2023, Pharmaceuticals (Basel, Switzerland),
Jimin Xu, and Judith Berastegui-Cabrera, and Haiying Chen, and Jerónimo Pachón, and Jia Zhou, and Javier Sánchez-Céspedes
Tetracyclic sulfones as potent gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
June 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!